| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 09/20/2006 | EP1702917A1 Amide derivative and medicine |
| 09/20/2006 | EP1701959A1 Triazole derivatives as vasopressin antagonists |
| 09/20/2006 | EP1701953A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 09/20/2006 | EP1701952A1 Dutpase inhibitors |
| 09/20/2006 | EP1701951A2 Modulators of peripheral 5-ht receptors |
| 09/20/2006 | EP1701950A1 Ecstasy haptens and immunogens |
| 09/20/2006 | EP1701949A2 Assay for entactogens |
| 09/20/2006 | EP1701948A1 Assay for entactogens |
| 09/20/2006 | EP1701944A2 2-(amino-substituted)-4-aryl pyramidines and related compounds useful for treating inflammatory diseases |
| 09/20/2006 | EP1701942A1 Non-nucleotide reverse transcriptase inhibitors |
| 09/20/2006 | EP1701727A1 Dutpase inhibitors |
| 09/20/2006 | EP1701724A2 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1343780B1 Piperazine derivatives for treatment of bacterial infections |
| 09/20/2006 | EP1244627B1 Picolinic acid derivatives and their use as fungicides |
| 09/20/2006 | EP0889889B1 Piperazine and piperidine compounds |
| 09/20/2006 | CN1835946A Epoxy compound and cured epoxy resin product |
| 09/20/2006 | CN1835943A 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 09/20/2006 | CN1835942A Mucin synthesis inhibitors |
| 09/20/2006 | CN1835923A Process for preparation of 4-amino-3-quinolinecarbonitriles |
| 09/20/2006 | CN1835751A Therapeutic agents useful for treating pain |
| 09/20/2006 | CN1275954C Hydroxamic acid derivatives |
| 09/19/2006 | US7109351 Fused pyrrolecarboxamides; GABA brain receptor ligands |
| 09/19/2006 | US7109338 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. |
| 09/19/2006 | US7109337 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/19/2006 | US7109335 5-[4-(3-Methanesulfonyl-benzylamino)-5-trifluoromethyl-pyrimidin-2-ylamino]-1,3-dihydro-indol-2-one; inhibitors of the FAK protein tyrosine kinases, antiproliferative, antitumor |
| 09/19/2006 | US7109333 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects |
| 09/19/2006 | US7109228 Pyrazole derivatives |
| 09/19/2006 | US7109220 cyclin dependent kinase (CDK) inhibitors useful in treating or ameliorating a CDK mediated disorder consisting of cervical adenocarcinoma, colon carcinoma and malignant melanoma |
| 09/19/2006 | US7109219 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 09/19/2006 | US7109216 For therapy of psychiatric and neurological disorders |
| 09/19/2006 | US7109212 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 09/19/2006 | US7109211 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors |
| 09/19/2006 | US7109205 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 09/19/2006 | US7109200 Carbamate derivatives, process for producing the same and use thereof |
| 09/19/2006 | US7109197 Plant safening agents; nematocides; fungicides; bactericides; viricides |
| 09/19/2006 | US7109186 4-hydroxy-5-oxo-1-(2-[4-methylpiperazin-1-yl]ethyl)-2,5-dihydro-1H-pyrrole-3-carboxylic acid (3,4-dichlorobenzyl)-methyl-amide for human immunodeficiency virus (HIV) treatment |
| 09/19/2006 | US7109150 Preventing infestation of plants by phytopathogenic microorganisms; horticulture, agriculture |
| 09/19/2006 | CA2240845C New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 09/14/2006 | WO2006096358A1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists |
| 09/14/2006 | WO2006095713A1 Inhibitor of plasminogen activator inhibitor-1 |
| 09/14/2006 | WO2006095014A1 2- (4-0x0-4h-quinaz0lin-3-yl) acetamides and their use as vasopressin v3 antagonists |
| 09/14/2006 | WO2006094930A1 Hiv inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines |
| 09/14/2006 | WO2006094842A1 Acylated piperidihes as glycine transporter inhibitors |
| 09/14/2006 | WO2006094395A1 Preparation of acid addition salts of amine bases by solid phase-gas phase reactions |
| 09/14/2006 | WO2006094347A1 Bicyclic nucleosides and nucleotides as therapeutic agents |
| 09/14/2006 | WO2006067445A3 Csf-1r kinase inhibitors |
| 09/14/2006 | WO2006040113A3 Heterocyclic diamide insecticidal agents |
| 09/14/2006 | WO2006033505A8 Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or cholic acid derivatives |
| 09/14/2006 | WO2005112923A3 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes |
| 09/14/2006 | WO2005037257A3 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 09/14/2006 | US20060205945 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/14/2006 | US20060205804 Process for preparing 5-(4-fluorophenyl)-1-[2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl) ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 09/14/2006 | US20060205791 Pharmaceutical process and compounds prepared thereby |
| 09/14/2006 | US20060205790 Medicinal arylethanolamine compounds |
| 09/14/2006 | US20060205783 inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 09/14/2006 | US20060205774 4-(4-(Heterocyclylakoxy) phenyl-1-(heterocyclyl-carbonyl) piperidine derivavites and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's |
| 09/14/2006 | US20060205772 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type I |
| 09/14/2006 | US20060205767 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
| 09/14/2006 | US20060205751 Novel compounds |
| 09/14/2006 | US20060205750 Cardiovascular disorders; central nervous system disorders; metabolic diseases; therapy for eating disorders; trans-2-(2-fluorophenyl)-8-[3'-oxospiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-yl]purine |
| 09/14/2006 | US20060205749 Remedy and/or preventive for lung diseases |
| 09/14/2006 | US20060205740 Chemical compounds |
| 09/14/2006 | US20060205738 Capped pyrazinoylguanidine sodium channel blockers |
| 09/14/2006 | US20060205734 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/14/2006 | US20060205732 Nonphytotoxic; 4-Bromo-3-methoxy-N-4-[4(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide; 4-[(Allyloxycarbonyl)amino]-3-methoxy-N-4-[4-(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide |
| 09/14/2006 | US20060205722 Such as N-{1-[2-(1,3-dioxan-2-yl)ethyl]piperidin-4-yl}-N-(4-fluorobenzyl)-2-[4-(2-hydroxy-2-methylpropoxy)phenyl]acetamide; selective inverse agonists of 5-HT2A receptor with minimal monamine receptors subtype activity; antipsychotics with reduced side effects |
| 09/14/2006 | US20060205719 Novel compounds having an antibacterial activity |
| 09/14/2006 | US20060205715 6-(8-Pentylamino-5,6,7,8-tetrahydro-naphthalen-2-yloxy)-nicotinamide; increase metabolic energy consumption, and reduction of weight; obesity, antidiabetic agent, eating disorders; antidepressant, anxiolytic agent |
| 09/14/2006 | US20060205709 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 09/14/2006 | US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 09/14/2006 | CA2600886A1 Bicyclic nucleosides and nucleotides as therapeutic agents |
| 09/14/2006 | CA2599511A1 2-(4-oxo-4h-quinazolin-3-yl) acetamides and their use as vasopressin v3 antagonists |
| 09/13/2006 | EP1699780A1 Novel quinoline derivatives |
| 09/13/2006 | EP1699779A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 09/13/2006 | EP1699778A1 (4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics |
| 09/13/2006 | EP1699762A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension |
| 09/13/2006 | EP1699761A1 Cb1 modulator compounds |
| 09/13/2006 | EP1699455A1 Heterocyclic aspartyl protease inhibitors |
| 09/13/2006 | EP1699421A2 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 09/13/2006 | EP1664033A4 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof |
| 09/13/2006 | EP1414813B1 1,2,4-trioxolane antimalarials |
| 09/13/2006 | EP1412364B1 Platelet adp receptor inhibitors |
| 09/13/2006 | EP1401962B1 Method for increasing hydrophilicity of fluorescent label compounds |
| 09/13/2006 | EP1392684B1 Thiazole compounds useful as inhibitors of protein kinases |
| 09/13/2006 | EP1244621B1 Nitrile derivatives as cathepsin k inhibitors |
| 09/13/2006 | EP1218358B1 Therapeutic quinazoline compounds |
| 09/13/2006 | EP1054011B1 Novel antifungal compounds and process for producing the same |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1833470A Compound, charge transporting material and organic electroluminescent element |
| 09/13/2006 | CN1832945A Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 09/13/2006 | CN1832942A Novel process for the preparation of 2h-chromenes |
| 09/13/2006 | CN1832941A Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 09/13/2006 | CN1832939A Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 09/13/2006 | CN1832938A N-heterocyclyl phenyl-substituted cyclic ketoenols |
| 09/13/2006 | CN1832929A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 09/13/2006 | CN1832928A 5-membered heterocycle-based p38 kinase inhibitors |
| 09/13/2006 | CN1832745A 2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 09/13/2006 | CN1830976A Extractive of total benzofuran of benzoin plants, prepn. method and use thereof |
| 09/13/2006 | CN1830972A Y-type second-order non-linear optical luminophor contg. triphenylamine, prepn. method and use thereof |